Cyrus J. Lawrence’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-220
Closed -$17K 174
2024
Q2
$17K Sell
220
-13,457
-98% -$1.1M ﹤0.01% 145
2024
Q1
$1.19M Buy
+13,677
New +$1.17M 0.26% 47
2023
Q3
$7.43M Sell
94,872
-8
-0% -$670 2.04% 23
2023
Q2
$8.36M Buy
94,880
+81,206
+594% +$6.99M 1.81% 18
2023
Q1
$1.1M Sell
13,674
-250
-2% -$20.4K 0.32% 45
2022
Q4
$1.08M Buy
13,924
+6,497
+87% +$527K 0.32% 44
2022
Q3
$599K Sell
7,427
-60
-0.8% -$5.39K 0.12% 53
2022
Q2
$672K Sell
7,487
-10
-0.1% -$1.01K 0.19% 53
2022
Q1
$832K Buy
+7,497
New +$792K 0.19% 56

Other funds holding MDT

Cyrus J. Lawrence's MDT Position: Q3 2024 in Review

Cyrus J. Lawrence sold out of Medtronic (MDT) in Q3 2024, closing a stake of 220 shares — an estimated $17K sold.

Cyrus J. Lawrence first reported a position in MDT in Q1 2022 and held it in 9 quarters. The position peaked at $8.36M in Q2 2023. 2,069 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • Cyrus J. Lawrence reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
  • Cyrus J. Lawrence sold 220 Medtronic shares in Q3 2024, an estimated $17K.
  • Cyrus J. Lawrence first reported a position in Medtronic in Q1 2022 and held it in 9 quarters.
  • Cyrus J. Lawrence's Medtronic position peaked at $8.36M in Q2 2023.
  • 2,069 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on Cyrus J. Lawrence's 13F filing for Q3 2024, filed 12 Nov 2024.